Pontifax (Israel) IV, L.P., 10% Owner, Director at Keros Therapeutics, Inc. (KROS), bought 60,000 shares at $50.00 ($3.0M) on 2020-11-17, disclosed to the SEC on 2020-11-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.00 | 6,000 | $300K | 10.0% |
| 2 | $50.00 | 12,966 | $648K | 21.6% |
| 3 | $50.00 | 14,400 | $720K | 24.0% |
| 4 | $50.00 | 26,634 | $1.3M | 44.4% |
| Total | $50.00 avg | 60,000 | $3.0M | 100% |